1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Mettler-Toledo reported second-quarter 2025 reported sales of $983.2 million, up 4% from a year earlier, and adjusted EPS of $10.09, up 5%. GAAP diluted EPS fell to $9.76 from $10.37, which included a one-time non-cash tax benefit in the prior-year period. The company raised its full-year 2025 adjusted EPS forecast to $42.10 to $42.60 from $41.25 to $42.00, while local currency sales growth guidance of 1% to 2% was unchanged.
Q2 2025 reported sales rose 4% to $983.2 million; local currency sales rose 2%.
Q2 diluted EPS was $9.76 vs. $10.37 a year earlier, which included a $1.07 per share one-time tax benefit; adjusted EPS was $10.09 vs. $9.65.
Full-year 2025 adjusted EPS forecast raised to $42.10 to $42.60, from $41.25 to $42.00.
Estimated gross incremental tariff costs were cut to approximately $60 million annualized from $115 million, due to lower tariff rates.
Cousins Properties reported second quarter 2025 net income available to common stockholders of $14.5 million, or $0.09 per share, up from $7.8 million, or $0.05 per share, a year earlier. The company raised its full-year 2025 FFO guidance to $2.79 to $2.85 per share from $2.75 to $2.83, and it said it acquired The Link, a Dallas office property, for $218.0 million on July 28, 2025.
Q2 2025 FFO was $117.5 million, or $0.70 per share, compared with $103.3 million, or $0.68 per share, in Q2 2024
2025 net income guidance was raised to $0.28 to $0.34 per share from $0.26 to $0.34 per share
The Link, a 292,000 square foot office property in Uptown Dallas, was acquired on July 28 for $218.0 million
Company issued $500.0 million of 5.250% senior notes in Q2 and repaid $250.0 million of 3.91% private notes after quarter end
Mirion reported second-quarter 2025 revenue of $222.9 million, up 7.6% from a year earlier, and swung to GAAP net income of $8.5 million from a net loss of $12.0 million. The company raised its full-year 2025 guidance for total revenue growth, Adjusted EBITDA, Adjusted Free Cash Flow and Adjusted EPS, while lowering its Organic Revenue growth range.
Q2 2025 revenue rose 7.6% to $222.9 million; GAAP net income was $8.5 million versus a $12.0 million loss in Q2 2024
Adjusted EBITDA was $51.2 million, up 4.9%; GAAP diluted EPS was $0.03 and Adjusted EPS was $0.11
2025 total revenue growth guidance raised to approximately 7.0%–9.0% from 5.0%–7.0%; Adjusted EBITDA guidance raised to $223 million–$233 million
Organic Revenue growth guidance revised down to approximately 5.0%–7.0% from 5.5%–7.5%, citing reductions in Labs & Research and Dosimetry Services
Omega Healthcare Investors reported second-quarter 2025 net income of $140 million and adjusted funds from operations (AFFO) of $232 million, both up from a year earlier, and raised its full-year 2025 AFFO guidance to $3.04 to $3.07 per share from $2.95 to $3.01. The company also disclosed that tenant Genesis Healthcare filed for Chapter 11 bankruptcy on July 9, 2025, and said it expects to keep receiving full rent from Genesis during the process.
Q2 2025 AFFO was $232 million, or $0.77 per share, versus $185 million, or $0.71 per share, in Q2 2024.
Q2 2025 net income was $140 million, or $0.46 per share, versus $117 million, or $0.45 per share, a year earlier.
Full-year 2025 AFFO guidance was raised to $3.04 to $3.07 per diluted share from $2.95 to $3.01.
Genesis filed for Chapter 11 on July 9, 2025; Omega agreed to provide an $8.0 million debtor-in-possession financing.
Envista reported second-quarter 2025 sales of $682 million, up from $633 million a year earlier, and GAAP net income of $26 million, compared with a net loss of $1,152 million in the prior-year quarter that included a goodwill and intangible asset impairment. The company raised its full-year 2025 guidance, lifting core sales growth to 3% to 4% and adjusted diluted EPS to $1.05 to $1.15 from prior ranges of 1% to 3% and $0.95 to $1.05.
Q2 2025 sales were $682.1 million; core sales growth was 5.6%, and adjusted diluted EPS was $0.26, up from $0.11.
GAAP diluted EPS was $0.16 in Q2 2025, compared with a loss of $6.69 in Q2 2024.
Full-year 2025 adjusted diluted EPS guidance is $1.05 to $1.15, up from $0.95 to $1.05; core sales growth guidance is 3% to 4%, up from 1% to 3%.
During Q2 2025 the company repurchased 4.8 million shares for about $82 million and had $150 million remaining under its repurchase program.
SPX Technologies reported second-quarter 2025 revenue of $552.4 million, up 10.2%, and GAAP EPS of $1.10, up 14.6%, and raised its full-year 2025 guidance for revenue, adjusted EBITDA and adjusted EPS. For shareholders, the higher outlook reflects the company's view of demand and operations, while total debt rose to $1,019.3 million from $614.7 million at year-end 2024.
Q2 2025 revenue was $552.4 million, up 10.2%; GAAP income from continuing operations was $52.5 million, up 16.2%.
Full-year adjusted EBITDA guidance raised to $485 million to $510 million from $470 million to $495 million.
Full-year revenue guidance raised to $2.225 billion to $2.275 billion from $2.20 billion to $2.26 billion; adjusted EPS guidance raised to $6.35 to $6.65 from $6.10 to $6.40.
Total debt was $1,019.3 million at June 28, 2025, compared with $614.7 million at December 31, 2024.
Boot Barn reported first-quarter fiscal 2026 net sales of $504.1 million, up 19.1% from a year earlier, and net income of $53.4 million, or $1.74 per diluted share, compared with $1.26 a year earlier. The company raised its full-year fiscal 2026 outlook, now expecting net income per diluted share of $5.80 to $6.70, which matters to shareholders because it sets updated profit and sales expectations for the year.
Net sales rose 19.1% to $504.1 million; consolidated same store sales rose 9.4%.
Net income was $53.4 million, or $1.74 per diluted share, versus $38.9 million, or $1.26, a year earlier.
Full-year fiscal 2026 guidance: total sales of $2.100 billion to $2.180 billion and net income per diluted share of $5.80 to $6.70.
Second-quarter guidance calls for net income per diluted share of $1.19 to $1.27, with total sales of $487 million to $495 million.
Universal Display reported second quarter 2025 revenue of $171.8 million, up from $158.5 million a year earlier, and net income of $67.3 million, or $1.41 per diluted share, versus $1.10 in the prior-year quarter. The company raised the low end of its 2025 revenue guidance, which it now projects at $650 million to $700 million, and declared a third quarter dividend of $0.45 per share.
Q2 2025 total revenue $171.8 million vs. $158.5 million in Q2 2024; royalty and license fees rose to $75.7 million from $59.6 million
Material sales fell to $88.7 million from $95.4 million, which the company attributed to customer mix and lower unit material volume
Net income $67.3 million, or $1.41 per diluted share, vs. $52.3 million, or $1.10, a year earlier
2025 revenue guidance raised at the low end to $650 million to $700 million; $0.45 quarterly dividend payable September 30, 2025 to holders of record on September 16, 2025
AMETEK reported second-quarter 2025 net sales of $1.78 billion, up 2.5% from a year earlier, and GAAP diluted earnings of $1.55 per share versus $1.45. The company raised its full-year 2025 adjusted earnings guidance, citing the second-quarter results and its recently announced acquisition of FARO Technologies.
Q2 2025 net sales were $1.78 billion, up 2.5%; operating income rose 3% to $461.6 million.
Q2 GAAP diluted EPS was $1.55 versus $1.45; adjusted diluted EPS was $1.78, up 7% from $1.66.
2025 adjusted diluted EPS guidance is now $7.06 to $7.20, up from $7.02 to $7.18; overall sales are expected to rise mid-single digits.
Q3 2025 adjusted diluted EPS is expected at $1.72 to $1.76, and third-quarter sales are expected to rise mid-single digits.
EMCOR Group reported record second-quarter 2025 revenue of $4.30 billion, up 17.4%, and diluted EPS of $6.72, up 28.0%, with a record $11.91 billion in remaining performance obligations. The company raised its full-year 2025 non-GAAP diluted EPS guidance to $24.50-$25.75 from $22.65-$24.00 and narrowed its revenue guidance to $16.4 billion-$16.9 billion.
Q2 2025 revenue $4.30 billion, up 17.4% from $3.67 billion; net income $302.2 million, or $6.72 per diluted share
Operating margin 9.6% in Q2 2025 versus 9.1% a year earlier
Full-year 2025 non-GAAP diluted EPS guidance raised to $24.50-$25.75 from $22.65-$24.00; operating margin guidance raised to 9.0%-9.4%
Remaining performance obligations reached a record $11.91 billion as of June 30, 2025, up 32.4%
IDACORP reported second quarter 2025 net income attributable to IDACORP of $95.8 million, or $1.76 per diluted share, up from $89.5 million, or $1.71 per diluted share, a year earlier. It raised the lower end of its full-year 2025 earnings guidance to $5.70 to $5.85 per diluted share from $5.65 to $5.85, with the upper end unchanged.
Q2 2025 net income was $95.8 million ($1.76 per diluted share) versus $89.5 million ($1.71) in Q2 2024.
Six-month 2025 earnings were $2.87 per diluted share, compared with $2.67 in the first six months of 2024.
2025 EPS guidance is now $5.70 to $5.85, assuming Idaho Power uses $60 million to $77 million of additional tax credits under the Idaho regulatory mechanism.
Higher retail revenues per MWh, customer growth, and usage were partly offset by higher depreciation and financing costs, according to the company.
APi Group reported second-quarter 2025 net revenue of $1.99 billion, up 15.0%, and reported net income of $77 million, up 11.6%. The company raised its full-year 2025 guidance for net revenue and adjusted EBITDA, and gave third-quarter guidance of $1.985 billion to $2.035 billion in net revenue, while gross margin fell 50 basis points.
Q2 2025 net revenue $1.99 billion, up 15.0% (8.3% organic); diluted EPS $0.16 versus $0.15 a year earlier
Adjusted EBITDA $272 million, up 17.7%; adjusted EBITDA margin rose 30 basis points to 13.7%
Full-year 2025 net revenue guidance raised to $7.65 billion to $7.85 billion, from $7.40 billion to $7.60 billion
Full-year adjusted EBITDA guidance raised to $1,005 million to $1,045 million, from $985 million to $1,035 million
Xylem reported second-quarter 2025 revenue of $2.3 billion, up 6% on both reported and organic bases, and earnings per share of $0.93, up 16%. The company raised its full-year 2025 revenue and adjusted earnings per share guidance, which matters to shareholders because both headline measures improved and the outlook was lifted.
Q2 2025 revenue was $2.3 billion, up 6% on reported and organic bases.
Q2 net income attributable to Xylem was $226 million, or $0.93 per share, up 16%; adjusted EPS was $1.26, also up 16%.
Full-year 2025 adjusted EPS guidance was raised to $4.70 to $4.85 from $4.50 to $4.70.
Full-year 2025 revenue is now forecast at about $8.9 to $9.0 billion, up about 4 to 5% on a reported basis, versus 1 to 2% previously.
Indivior PLC (Nasdaq: INDV) reported second-quarter 2025 results with total net revenue of $302 million, up 1% from a year earlier, and net income of $18 million, compared with a net loss of $97 million in Q2 2024. The company raised its full-year 2025 net revenue guidance to $1,030 million to $1,080 million and its adjusted EBITDA guidance to $275 million to $300 million, but Q2 adjusted EBITDA fell to $88 million from $93 million as marketing spending increased.
Q2 2025 total net revenue of $302 million, up 1% from $299 million in Q2 2024; U.S. SUBLOCADE net revenue rose 9% to $195 million
Q2 2025 net income of $18 million and diluted EPS of $0.14, versus a net loss of $97 million and diluted loss of $0.72 per share a year earlier
FY 2025 net revenue guidance raised to $1,030 million to $1,080 million from $955 million to $1,025 million; adjusted EBITDA guidance raised to $275 million to $300 million from $220 million to $260 million
Q2 2025 adjusted EBITDA of $88 million, down from $93 million, mainly reflecting increased marketing for U.S. SUBLOCADE
Kimco Realty reported second-quarter 2025 net income available to common shareholders of $155.4 million, or $0.23 per diluted share, up from $0.17 a year earlier, and raised its 2025 net income and FFO per share outlook. FFO per diluted share rose 7.3% to $0.44, supporting the higher full-year guidance for shareholders.
Q2 2025 net income per diluted share was $0.23 vs. $0.17 in Q2 2024; FFO per diluted share was $0.44, up 7.3%.
2025 FFO per diluted share outlook raised to $1.73 to $1.75 from $1.71 to $1.74; net income outlook raised to $0.74 to $0.76 from $0.70 to $0.73.
Same property NOI rose 3.1% in the quarter; small shop occupancy reached a record 92.2%.
Quarterly common dividend of $0.25 per share declared, payable September 19, 2025, to holders of record September 5, 2025.
Vontier reported second-quarter 2025 sales of $773.5 million, up 11.1% from a year earlier, and adjusted diluted EPS of $0.79 versus $0.63 a year earlier. The company raised its full-year 2025 adjusted diluted EPS guidance to $3.10 to $3.20 and gave Q3 2025 adjusted EPS guidance of $0.74 to $0.78, which gives shareholders a higher profit outlook for the year.
Q2 2025 sales were $773.5 million, up 11.1%; core sales rose 10.8%
GAAP diluted EPS was $0.62 versus $0.45 a year earlier; adjusted diluted EPS was $0.79 versus $0.63
Full-year 2025 adjusted diluted EPS guidance raised to $3.10 to $3.20; Q3 2025 guidance is $0.74 to $0.78
Repurchased about 1.4 million shares for about $50 million in Q2; $105 million year to date
ITT reported second-quarter 2025 revenue of $972.4 million, up 7.3% from a year earlier, and diluted EPS of $1.52, up 4.8%. The company raised its full-year 2025 revenue and EPS guidance, citing year-to-date performance and a more stable demand outlook for the second half.
Q2 revenue of $972.4 million rose 7.3% (4.3% organic) versus the prior year quarter.
Q2 diluted EPS was $1.52, up 4.8%; adjusted EPS was $1.64, up 10.1%.
2025 guidance: revenue growth of 5% to 7%, EPS of $5.95 to $6.15, and adjusted EPS of $6.35 to $6.55.
Quarterly dividend of $0.351 per share is payable September 29, 2025 to holders of record on September 2, 2025.
Biogen reported second quarter 2025 revenue of $2.6 billion, up 7% from a year earlier, with GAAP diluted EPS of $4.33, up 8%, and non-GAAP diluted EPS of $5.47, up 4%. The company raised its full-year 2025 non-GAAP diluted EPS guidance to $15.50-$16.00 from $14.50-$15.50, and its revenue outlook to roughly flat at constant currency from a mid-single-digit decline, which points to higher expected earnings for shareholders.
Q2 2025 total revenue was $2,646 million, up 7% year over year; GAAP diluted EPS was $4.33 and non-GAAP diluted EPS was $5.47.
Full-year 2025 non-GAAP diluted EPS guidance was raised to $15.50-$16.00 from $14.50-$15.50, including a $0.87 benefit from a stronger outlook partly offset by a ~$0.12 impact from the City Therapeutics transaction.
Q2 results included about $47 million of acquired IPR&D, upfront and milestone expense, an approximately $0.26 per-share impact.
Biogen expects minimal contract manufacturing revenue in Q4 2025 due to planned plant maintenance and expects increased competitive pressure on ex-U.S. MS sales in the second half.
Antero Midstream reported second quarter 2025 net income of $125 million, or $0.26 per diluted share, up 44% per share from a year earlier, and Adjusted EBITDA of $284 million, up 11%. The company raised its 2025 guidance for net income and Adjusted EBITDA by $10 million at the midpoint and for Free Cash Flow after dividends by $25 million, to a range of $275 million to $325 million.
Q2 2025 net income was $125 million, or $0.26 per diluted share, versus $0.18 a year earlier
Adjusted EBITDA was $284 million, up 11% year over year; Free Cash Flow after dividends was $82 million, up 89%
2025 guidance: net income midpoint raised $10 million; Free Cash Flow after dividends now $275 million to $325 million
Leverage fell to 2.8x as of June 30, 2025; about $83 million of shares bought back year to date through July 30, 2025
American Water reported second-quarter 2025 diluted earnings of $1.48 per share, up from $1.42 a year earlier, and first-half earnings of $2.53 per share, up from $2.37. The company narrowed its 2025 EPS guidance to $5.70 to $5.75 from $5.65 to $5.75, on a weather-normalized basis, which raises the low end of the range and affirms its long-term targets. Shareholders also get a quarterly dividend of $0.8275 per share and news of a pending purchase of Nexus Water Group systems.
Q2 2025 operating revenues were $1,276 million, up from $1,149 million; Q2 net income attributable to common shareholders was $289 million, up from $277 million.
2025 EPS guidance range is now $5.70 to $5.75, narrowed from $5.65 to $5.75; long-term EPS and dividend growth targets of 7-9% were affirmed.
Q2 results include an estimated net unfavorable weather impact of $0.06 per share for the quarter and the six-month comparison.
Board declared a quarterly dividend of $0.8275 per share, payable September 3, 2025, to holders of record as of August 12, 2025.
Q2 Holdings reported second-quarter 2025 revenue of $195.1 million, up 13% from a year earlier, and GAAP net income of $11.8 million, compared with a net loss of $13.1 million in the prior-year quarter. The company raised its full-year 2025 guidance for revenue, adjusted EBITDA and free cash flow conversion, and it gave third-quarter guidance. The results and higher outlook matter to shareholders because they show revenue growth and profitability improving compared with last year.
Q2 2025 revenue was $195.1 million, up 13% year over year and 3% from the first quarter of 2025.
GAAP net income was $11.8 million, compared with a net loss of $13.1 million in Q2 2024; adjusted EBITDA was $45.8 million, up from $29.9 million.
Full-year 2025 revenue guidance is $783.0 million to $788.0 million, and adjusted EBITDA guidance is $177.0 million to $181.0 million.
Third-quarter 2025 revenue guidance is $196.0 million to $200.0 million, and adjusted EBITDA guidance is $44.0 million to $47.0 million.
Kite Realty Group reported net income attributable to common shareholders of $110.3 million, or $0.50 per diluted share, for the quarter ended June 30, 2025, compared with a net loss of $48.6 million a year earlier, which included $66.2 million of impairment charges. The company raised its 2025 NAREIT FFO and Core FFO guidance, which matters to shareholders because it signals higher expected operating results for the year.
Q2 2025 net income attributable to common shareholders was $110.3 million, or $0.50 per diluted share, versus a net loss of $48.6 million, or $0.22 per share, in Q2 2024.
Core FFO of the Operating Partnership was $0.50 per diluted share, the same as in Q2 2024.
2025 NAREIT FFO guidance raised to $2.06 to $2.10 per diluted share from $2.04 to $2.10; Core FFO guidance raised to $2.02 to $2.06 from $2.00 to $2.06.
Third quarter 2025 dividend declared at $0.27 per common share, a 3.8% year-over-year increase.
VICI Properties reported second-quarter 2025 results on July 30, 2025, with revenue up 4.6% year over year to $1.0 billion and AFFO up 6.4% to $630.2 million. The company raised its full-year 2025 AFFO guidance to $2,500 million to $2,520 million, or $2.35 to $2.37 per diluted share, from $2,470 million to $2,500 million, or $2.33 to $2.36 per share, previously. Net income rose 16.7% to $865.1 million, but the company said the increase was driven largely by a $99.0 million change in the non-cash CECL allowance.
Second-quarter revenue was $1.0 billion, up 4.6% from $957.0 million a year earlier.
AFFO was $630.2 million, or $0.60 per share, up 4.9% per share from $0.57.
Net income was $865.1 million, or $0.82 per share, driven by a $99.0 million change in the CECL allowance.
Full-year 2025 AFFO per share guidance was raised to $2.35 to $2.37 from $2.33 to $2.36.
ITW reported second-quarter 2025 revenue of $4.1 billion, up 1%, with flat organic growth, and GAAP EPS of $2.58, up 2%. The company raised its full-year 2025 GAAP EPS guidance by $0.10 to a narrower range of $10.35 to $10.55 per share, which benefits shareholders if the outlook holds.
Q2 2025 revenue of $4.1 billion, up 1%; organic growth essentially flat
GAAP EPS of $2.58 in Q2, up 2%; operating margin 26.3%, up 10 basis points
Full-year 2025 GAAP EPS guidance raised to $10.35 to $10.55 per share from $10.15 to $10.55
Q2 free cash flow of $449 million, down from $571 million a year earlier; $375 million of shares repurchased in the quarter
Vita Coco reported second quarter 2025 net sales of $169 million, up 17% from a year earlier, and net income of $23 million, or $0.38 per diluted share, compared with $0.32 a year earlier. The company raised its full year 2025 net sales outlook to $565 million to $580 million, but gross margin fell to 36% from 41% and Non-GAAP Adjusted EBITDA declined to $29.2 million from $32.2 million.
Q2 2025 net sales rose 17% to $169 million; Vita Coco Coconut Water net sales grew 25%.
Net income was $23 million, or $0.38 per diluted share, versus $19 million, or $0.32, in Q2 2024.
Gross margin was 36% versus 41%; Non-GAAP Adjusted EBITDA was $29.2 million versus $32.2 million.
Full year 2025 net sales are now expected at $565 million to $580 million; Adjusted EBITDA at $86 million to $92 million.
Urban Edge Properties reported second-quarter 2025 results on July 30, 2025 and raised its full-year 2025 FFO as Adjusted guidance by $0.025 per share at the midpoint. Quarterly net income attributable to common shareholders rose to $57.98 million, or $0.46 per diluted share, from $30.76 million, or $0.26, a year earlier, though the gain on property sales drove much of the increase.
Q2 2025 FFO as Adjusted was $0.36 per diluted share, up from $0.32 a year earlier; the CEO called it a quarterly record.
Q2 2025 net income included a $49.5 million, or $0.39 per diluted share, gain on sale of real estate from three non-core dispositions.
Full-year 2025 FFO as Adjusted guidance was raised to $1.40-$1.44 per diluted share from $1.37-$1.42.
Shop leased occupancy reached 92.5% as of June 30, 2025, up 270 basis points from June 30, 2024.
GE HealthCare reported second quarter 2025 revenue of $5.0 billion, up 3% from a year earlier, and net income attributable to the company of $486 million versus $428 million. It raised its full-year 2025 adjusted EPS guidance to $4.43 to $4.63 from $3.90 to $4.10, and its free cash flow guidance to at least $1.4 billion from at least $1.2 billion. Adjusted EBIT margin fell to 14.6% from 15.3%, which the company attributed mainly to tariffs.
Q2 2025 revenue was $5.0 billion, up 3% reported and 2% organic year over year.
Diluted EPS was $1.06 versus $0.93; adjusted EPS was $1.06 versus $1.00.
2025 adjusted EPS guidance raised to $4.43 to $4.63 from $3.90 to $4.10, including about $0.45 of tariff impact.
Adjusted EBIT margin was 14.6% versus 15.3%, down 80 bps, impacted by tariffs.
Trane Technologies reported second-quarter 2025 net revenues of $5.7 billion, up 8 percent, with GAAP continuing EPS of $3.87, up 16 percent, and adjusted continuing EPS of $3.88, up 18 percent. The company raised its full-year 2025 revenue and EPS guidance, now expecting reported revenue growth of about 9 percent and adjusted continuing EPS of about $13.05.
Q2 2025 net revenues of $5,746 million, up 8 percent; GAAP continuing EPS $3.87 versus $3.33 a year earlier
Full-year 2025 guidance: reported revenue growth of about 9 percent, GAAP continuing EPS of about $13.30, adjusted continuing EPS of about $13.05
Record enterprise bookings of $5.6 billion, up 5 percent; backlog of $7.1 billion at June 30, 2025
EXL reported second-quarter 2025 revenue of $514.5 million, up 14.7% from a year earlier, and raised its full-year 2025 revenue and adjusted diluted EPS guidance. The company also agreed on July 29, 2025 to pay Citibank $125 million under an accelerated share repurchase, part of its $500 million buyback program.
Q2 2025 revenue of $514.5 million, up 14.7%; diluted EPS of $0.40 versus $0.28, and adjusted diluted EPS of $0.49 versus $0.40
2025 revenue guidance raised to $2.050 billion to $2.070 billion from $2.035 billion to $2.065 billion
2025 adjusted diluted EPS guidance raised to $1.86 to $1.90 from $1.83 to $1.89
Adjusted operating income margin was 19.6%, down from 19.8% a year earlier; $125 million accelerated share repurchase with Citibank under the $500 million program
GATX reported second-quarter 2025 net income of $75.5 million, or $2.06 per diluted share, up from $44.4 million, or $1.21, a year earlier, and raised its full-year 2025 earnings guidance to $8.50 to $8.90 per diluted share. Total revenues rose to $430.5 million from $386.7 million, while Rail Europe fleet utilization fell to 93.3% from 95.8% a year earlier. For shareholders, the higher guidance reflects year-to-date results and expected stronger second-half performance at Engine Leasing.
Q2 2025 net income was $75.5 million, or $2.06 per diluted share, compared with $44.4 million, or $1.21, in Q2 2024.
Q2 2025 total revenues were $430.5 million, compared with $386.7 million in Q2 2024.
2025 full-year diluted EPS guidance was raised to $8.50 to $8.90, excluding tax benefits and other items and the pending Wells Fargo rail asset acquisition.
The Brookfield Infrastructure joint venture to acquire Wells Fargo's rail assets is expected to close in Q1 2026 or sooner, subject to regulatory approvals.
CBRE reported second-quarter 2025 results on July 29, 2025, with revenue up 16% to $9.8 billion and GAAP net income up 65% to $215 million. The company raised its 2025 core EPS outlook to $6.10 to $6.20 from $5.80 to $6.10, which would be higher by at least $0.10 based on current forward currency rates.
Q2 2025 GAAP EPS rose 71% to $0.72 and core EPS rose 47% to $1.19.
Q2 revenue rose 16% to $9.8 billion; Q2 free cash flow was $2 million, down from $220 million a year earlier.
Stock repurchases since year-end 2024 totaled about 5.2 million shares for $663 million, with about $5.2 billion of authorization remaining as of June 30, 2025.
Royal Caribbean reported second-quarter 2025 diluted EPS of $4.41, up from $3.11 a year earlier, and total revenues of $4.5 billion, up from $4.1 billion. The company raised its full-year 2025 Adjusted EPS guidance to $15.41 to $15.55, which it said reflects stronger second-quarter performance and lower expected spending.
Q2 2025 diluted EPS was $4.41 vs. $3.11 in Q2 2024; Adjusted EPS was $4.38 vs. $3.21.
Total revenues were $4.5 billion for the quarter, vs. $4.1 billion a year earlier.
Full-year 2025 Adjusted EPS guidance is $15.41 to $15.55, which the company says is approximately 31% growth year over year.
Third-quarter 2025 Adjusted EPS is guided to $5.55 to $5.65.
Armstrong World Industries reported second-quarter 2025 net sales of $424.6 million, up 16.3%, and diluted EPS of $2.01, up 34%. The company raised its full-year 2025 guidance for net sales, adjusted EBITDA, adjusted diluted EPS and adjusted free cash flow, citing strong results in the first half.
Q2 operating income rose 29.7% to $123.2 million; operating margin was 29.0%, up 300 basis points.
Full-year 2025 adjusted diluted EPS guidance raised to $7.15 to $7.30, from a 2024 actual of $6.31.
Full-year 2025 net sales guidance raised to $1.600 billion to $1.630 billion, versus $1.446 billion in 2024.
Company repurchased shares for $30 million in Q2 and had $610 million remaining under its buyback authorization as of June 30, 2025.
Veralto reported second-quarter 2025 sales of $1,371 million, up 6.4% from a year earlier, and diluted GAAP earnings per share of $0.89 versus $0.81 a year earlier. The company raised its full-year 2025 adjusted earnings per share guidance to $3.72-$3.80 from $3.60-$3.70, which points to higher expected profit for shareholders.
Q2 sales were $1,371 million, up 6.4%; non-GAAP core sales grew 4.8%
Net earnings were $222 million, or $0.89 per diluted share, versus $0.81 a year earlier
Adjusted diluted EPS was $0.93, compared with $0.85 in the prior-year quarter
Full-year 2025 adjusted EPS guidance raised to $3.72-$3.80; third-quarter adjusted EPS guidance is $0.91-$0.95
Crane Company reported second quarter 2025 sales of $577.2 million, up 9.2%, and GAAP earnings per diluted share from continuing operations of $1.37, up 20% from $1.14 a year earlier. The company raised its full-year 2025 adjusted EPS outlook to $5.50-$5.80 from $5.30-$5.60, citing strong orders and backlog growth at its Aerospace & Electronics segment.
Q2 adjusted EPS from continuing operations was $1.49, up 24% from $1.20; GAAP EPS from continuing operations was $1.37, up 20%.
Core order growth was 19.6% and core backlog growth was 18.2%; total backlog reached $1,455.9 million at June 30, 2025.
Full-year adjusted EPS outlook raised to $5.50-$5.80 from $5.30-$5.60; the company also declared a $0.23 per share third quarter dividend payable September 10, 2025.
Agreement to acquire Precision Sensors & Instrumentation from Baker Hughes, announced June 9, 2025, is expected to close at year-end.
Woodward reported third-quarter fiscal 2025 net sales of $915 million, up 8%, and diluted EPS of $1.76, up 8%. It raised full-year sales guidance to $3.45 billion-$3.525 billion and adjusted EPS guidance to $6.50-$6.75, but lowered adjusted free cash flow guidance to $315 million-$350 million, which the company tied to supporting higher sales in a dynamic supply chain and production environment.
Q3 net sales $915 million, up 8%; diluted EPS $1.76 versus $1.63 a year earlier
FY2025 adjusted EPS guidance raised to $6.50-$6.75 from $5.95-$6.25
FY2025 adjusted free cash flow guidance lowered to $315 million-$350 million from $350 million-$400 million
HCA Healthcare reported second-quarter 2025 revenue of $18.605 billion, up 6.4% from a year earlier, and net income attributable to the company of $1.653 billion, or $6.83 per diluted share, up 23.5%. The company raised its 2025 guidance, with diluted EPS now expected at $25.50 to $27.00, up from $24.05 to $25.85. The Board also declared a $0.72 per share quarterly dividend payable September 30, 2025.
Revenue of $18.605 billion, up 6.4% from $17.492 billion; net income attributable to HCA of $1.653 billion versus $1.461 billion
Adjusted EBITDA of $3.849 billion, up 8.4%; operating cash flow of $4.210 billion versus $1.971 billion a year earlier
Revised 2025 guidance: revenue $74.00 billion to $76.00 billion; net income attributable to HCA $6.11 billion to $6.48 billion; Adjusted EBITDA $14.70 billion to $15.30 billion
Quarterly dividend of $0.72 per share, record date September 16, 2025, payment date September 30, 2025
Edwards Lifesciences reported second-quarter 2025 sales of $1.53 billion, up 11.9% from a year earlier, and adjusted EPS of $0.67. The company raised its full-year 2025 sales growth guidance to 9% to 10% and its adjusted EPS outlook to the high end of $2.40 to $2.50. GAAP net income attributable to Edwards fell to $333.2 million from $366.3 million, partly due to a $47.1 million impairment loss.
Q2 sales $1.53 billion, up 11.9%; TAVR sales $1.1 billion, up 8.9%; TMTT sales $134.5 million, up 61.9%
Full-year 2025 sales guidance raised to 9% to 10%, or $5.9 billion to $6.1 billion; TAVR sales guidance raised to $4.3 billion to $4.5 billion
Adjusted diluted EPS $0.67 in Q2; full-year adjusted EPS now expected at the high end of $2.40 to $2.50
Q2 GAAP diluted EPS $0.56 versus $0.61 a year earlier, including a $47.1 million loss on impairment
Phillips Edison & Company reported second quarter 2025 results on July 24, 2025, with Core FFO up 10.3% to $88.2 million and total revenues of $177.8 million, while net income attributable to stockholders fell to $12.8 million from $15.3 million. The company raised its full-year 2025 Core FFO per share guidance to $2.55 to $2.60 from $2.52 to $2.59, which matters to shareholders because it signals higher expected earnings for the year.
Q2 2025 net income attributable to stockholders was $12.8 million, or $0.10 per diluted share, compared with $15.3 million, or $0.12, in Q2 2024.
Q2 2025 Core FFO rose 10.3% to $88.2 million, or $0.64 per diluted share, from $80.0 million, or $0.59, a year earlier.
Full-year 2025 Core FFO per share guidance was raised to $2.55 to $2.60 from $2.52 to $2.59.
Management will discuss results on a conference call and webcast on Friday, July 25, 2025, at 12:00 p.m. Eastern Time.
The Ensign Group reported second-quarter 2025 GAAP diluted earnings per share of $1.44, up 18.0% from the prior year quarter, and GAAP net income of $84.4 million, up 18.9%. The company raised its full-year 2025 diluted EPS guidance to $6.34 to $6.46 from $6.22 to $6.38, and its revenue guidance to $4.99 billion to $5.02 billion from $4.89 billion to $4.94 billion, which matters to shareholders because it signals higher expected profit and sales for the year.
Q2 2025 total revenue was $1.23 billion, up 18.5% from the prior year quarter.
GAAP diluted EPS was $1.44 versus $1.22 a year earlier; adjusted diluted EPS was $1.59, up 20.5%.
2025 diluted EPS guidance raised to $6.34 to $6.46; revenue guidance raised to $4.99 billion to $5.02 billion.
Cash on hand was approximately $364.0 million, with $592.6 million of available line-of-credit capacity.
West Pharmaceutical Services reported second-quarter 2025 net sales of $766.5 million, up 9.2%, with diluted EPS of $1.82 versus $1.51 a year earlier. The company raised its full-year 2025 net sales guidance to $3.040 billion to $3.060 billion and its adjusted-diluted EPS guidance to $6.65 to $6.85, both up from prior ranges.
Q2 2025 net sales of $766.5 million rose 9.2%; organic net sales grew 6.8%.
Adjusted-diluted EPS was $1.84, compared with $1.52 in the second quarter of 2024.
Full-year 2025 adjusted-diluted EPS guidance rose to $6.65 to $6.85 from $6.15 to $6.35.
Board approved a fourth-quarter 2025 dividend of $0.22 per share, payable November 19, 2025 to holders of record as of November 12, 2025.
Wabtec reported second-quarter 2025 GAAP diluted earnings per share of $1.96, up 19.5%, and sales of $2.71 billion, up 2.3%. The company raised its 2025 adjusted EPS guidance to $8.55 to $9.15, which it attributed to first-half performance, acquisitions and cost management.
GAAP diluted EPS was $1.96 and adjusted diluted EPS was $2.27, up 15.8% from a year earlier.
Full-year 2025 adjusted EPS guidance rose to $8.55 to $9.15, up $0.20 at the mid-point.
Revenue guidance was raised by $200 million at the mid-point to a range of $10.925 billion to $11.225 billion, largely reflecting the Evident Inspection Technologies Division acquisition completed July 1, 2025.
Operating cash flow was $209 million versus $235 million a year earlier, partly due to delayed second-quarter locomotive deliveries.
Dover reported second-quarter 2025 results on July 24, 2025, with revenue of $2.0 billion, up 5% (1% organic), and GAAP diluted EPS from continuing operations of $2.03, up 14%. The company raised its full-year 2025 adjusted EPS guidance to $9.35-$9.55 from $9.20-$9.40, while GAAP EPS guidance remains $8.00-$8.20.
Q2 2025 adjusted diluted EPS from continuing operations was $2.44, up 16% from $2.10 a year earlier.
Six-month GAAP EPS from continuing operations was $3.76, down 38%, mainly due to the 2024 gain on the De-Sta-Co disposition.
Full-year 2025 adjusted EPS guidance was raised to $9.35-$9.55 from $9.20-$9.40, based on revenue growth of 4% to 6%.
Management said it completed two acquisitions in the Pumps & Process Solutions segment during the quarter.
Allegion reported second-quarter 2025 net revenues of $1,022.0 million, up 5.8%, and diluted earnings of $1.85 per share, up from $1.77 a year earlier. The company raised its full-year 2025 reported revenue growth outlook to 6.5% to 7.5% and its full-year EPS outlook to $7.25 to $7.40, or $8.00 to $8.15 on an adjusted basis.
Q2 2025 diluted EPS was $1.85 versus $1.77; adjusted EPS was $2.04, up 4.1%.
Q2 2025 revenue rose 5.8% to $1,022.0 million, with organic growth of 3.2%.
Q2 2025 operating margin was 21.5% versus 21.6%; adjusted operating margin was flat at 23.7%.
Full-year 2025 tariff costs are estimated at about $40 million, with the company expecting to offset them at the operating profit and EPS level, primarily through pricing actions.
Wyndham reported second-quarter 2025 fee-related and other revenues of $397 million, up 8% from a year earlier, and net income of $87 million, up 1%. Diluted EPS rose 6% to $1.13 and adjusted diluted EPS rose 18% to $1.33, and the company raised its full-year adjusted diluted EPS outlook to $4.60 to $4.78 from $4.57 to $4.74, citing second-quarter share repurchases. Global RevPAR fell 3% in constant currency, and the company now excludes rooms tied to its Super 8 master licensee in China from its reported system size, RevPAR and royalty rate metrics.
Fee-related and other revenues rose to $397 million from $366 million; net income rose to $87 million from $86 million.
Adjusted diluted EPS rose 18% to $1.33 from $1.13, including a $0.07 benefit from marketing fund variability; comparable growth was about 11%.
Full-year 2025 adjusted diluted EPS outlook raised to $4.60 to $4.78; adjusted EBITDA outlook unchanged at $730 million to $745 million.
Global RevPAR declined 3% in constant currency and U.S. RevPAR declined 4%; about 67,300 Super 8 China rooms as of March 31, 2025 are now excluded from reported metrics.
NETSTREIT reported second quarter 2025 results on July 23, 2025, with net income of $0.04 per diluted share, compared with a net loss of $0.03 a year earlier, and AFFO of $0.33 per diluted share, up from $0.32. The company raised its 2025 AFFO per share guidance and its net investment guidance, and increased its quarterly dividend by 2.4%. For shareholders, the filing shows higher earnings per share, a higher AFFO outlook and a larger dividend.
Q2 2025 net income was $0.04 per diluted share, versus a net loss of $0.03 in Q2 2024; AFFO was $0.33 per diluted share, versus $0.32.
Total revenues were $48.3 million for Q2 2025, compared with $39.6 million for Q2 2024.
2025 AFFO per share guidance was raised to $1.29 to $1.31 from $1.28 to $1.30; net investment guidance was raised to $125.0 million to $175.0 million from $75.0 million to $125.0 million.
Quarterly dividend increased to $0.215 per share, up 2.4%, payable September 15, 2025 to holders of record on September 2, 2025.
Lennox reported second-quarter 2025 revenue of $1.5 billion, up 3%, and segment profit of $354 million, up 11%. The company raised its full-year 2025 earnings per share guidance to $23.25 to $24.25 and expects revenue to rise about 3%, which signals stronger expected profitability for shareholders.
Q2 GAAP diluted EPS was $7.82, up from $6.87; adjusted diluted EPS rose 14% to $7.82
Segment profit rose 11% to $354 million, with segment margin up 170 basis points to 23.6%
Full-year 2025 EPS guidance is now $23.25 to $24.25; capital expenditures remain about $150 million
Q2 operating cash flow fell to $87 million from $184 million; the company repurchased $210 million of shares in the quarter
Crown Holdings reported second-quarter 2025 results on July 21, 2025, with adjusted diluted earnings per share up 19% to $2.15 and net sales of $3,149 million. The company raised its full-year 2025 adjusted diluted EPS guidance to $7.10 to $7.50, which signals stronger expected earnings for shareholders.
Q2 2025 adjusted diluted EPS rose 19% to $2.15 from $1.81; reported diluted EPS was $1.56 versus $1.45
Net sales were $3,149 million versus $3,040 million; income from operations was $391 million versus $379 million
Full-year 2025 adjusted diluted EPS guidance raised to $7.10 to $7.50; third-quarter adjusted EPS expected at $1.95 to $2.05
Adjusted free cash flow expected at approximately $900 million for 2025
Roper Technologies reported second quarter 2025 revenue up 13% to $1.94 billion, GAAP net earnings up 12% to $378 million, and adjusted DEPS up 9% to $4.87. The company raised its full-year 2025 adjusted DEPS guidance low end to $19.90 from $19.80 and lifted its total revenue growth outlook to about 13% from about 12%, while also announcing an $800 million acquisition of Subsplash expected to close later this month.
Q2 2025 revenue of $1.94 billion rose 13%, with organic growth of 7% and acquisitions adding 6%.
GAAP net earnings were $378 million, up 12%; adjusted DEPS was $4.87, up 9%.
Full-year 2025 adjusted DEPS guidance is $19.90 to $20.05, versus prior $19.80 to $20.05; total revenue growth outlook is about 13%, versus about 12% previously.
Roper signed a definitive agreement to acquire Subsplash for $800 million, with closing expected later in July 2025.
Autoliv reported record second-quarter 2025 net sales of $2,714 million, up 4.2%, and diluted EPS of $2.16, up 27% from a year earlier. The company raised its full-year 2025 organic sales growth guidance to around 3% and kept its adjusted operating margin guidance at around 10-10.5%.
Q2 2025 operating income rose 20% to $247 million; adjusted operating income rose 14% to $251 million.
Q2 2025 adjusted diluted EPS was $2.21, up 18%; operating cash flow fell 18% to $277 million.
Autoliv recovered around 80% of tariff costs in Q2 and expects to recover most of the remainder later in 2025.
Board announced a share repurchase program of up to $2.5 billion through 2029 and a dividend of $0.85 per share for Q3, up 21%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.